Industry Bulletins | March 16, 2015
Akili Interactive Labs Forms Clinical Collaboration Agreement With Autism Speaks’ Affiliate DELSIA LLC
Akili Interactive Labs, Inc. (Akili), a company that develops clinically-validated video games for cognitive assessment and personalized treatment, announced it entered into a clinical collaboration agreement with Delivering Scientific Innovation for Autism LLC (DELSIA). DELSIA is a not-for-profit venture philanthropy affiliate of Autism Speaks, a leading autism science and advocacy organization. DELSIA will fund a controlled study to determine the efficacy of Akili's cognitive gaming intervention platform in children with co-occurring high-functioning autism and ADHD.
Akili's cognitive platform, Project: EVO, is based on technology licensed from the lab of Dr. Adam Gazzaley at . . .